enquiry@technavio.com

Pharmaceutical Drug Delivery Market by Product Type, by Application and Geographic: Analysis, Size, Growth, Trends, and Forecast, 2024-2028

  • Published: Nov 2024
  • Pages: 160
Home Upcoming Report Pharmaceutical Drug Delivery Market

Market Size

info_image

The pharmaceutical drug delivery market is crucial for enhancing the efficacy, safety, and convenience of medications across various therapeutic areas. Specific approaches like inhalation products for respiratory disorders (e.g., asthma) and liposomal drug delivery systems (e.g., liposomal doxorubicin) for targeted therapies are gaining prominence.

Innovations in nanotechnology enable the development of nanocarriers for enhanced drug stability, solubility, and targeted delivery of therapeutic agents. Patient-friendly systems focus on improving bioavailability, effectiveness, and reducing side effects.

Market Report Highlights

Application
  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Others
Delivery Method
  • Nasal drug delivery
  • Ocular drug delivery
  • Oral drug delivery
  • Others
Regional Landscape
  • North America
  • Europe
  • APAC
  • South America
  • The Middle East and Africa
Key Companies Profiled
  • Sanofi S.A.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Bayer AG
  • Novartis AG

Market Report Insights

Technavio’s in-depth industry report offers historical data as well as a comprehensive market forecast. It analyzes the current state of the pharmaceutical drug delivery market and provides detailed predictions on its performance over the coming years. It examines key factors such as market drivers, challenges, and key emerging trends, as well as the global competitive landscape. Also included is a breakdown of the types of products available on the market, along with their market shares and future prospects.

Market Segmentation

The pharmaceutical drug delivery market is segmented according to application, route of administration, and region. Technavio’s industry report provides actionable market insights on each segment, including market share and growth forecasts. North America is a leading region of the global market, being home to many large drug producers along with well-funded healthcare industries. The growing prevalence of diabetes in the region is also boosting demand.

Application Segmentation

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Others

Route of Administration Segmentation

  • Nasal drug delivery
  • Ocular drug delivery
  • Oral drug delivery
  • Topical drug delivery
  • Other drug delivery

Regional Analysis

Different parts of the world will have different demands, supply chain logistics, legal nuances, and other factors to take into consideration when entering a new market. Technavio’s pharmaceutical drug delivery market research helps facilitate strategic business decisions by providing a historical and focused look at regional markets, including market trends, drivers, and challenges as well as predictions for regional market sizes and growth.

Geographical Segmentation:

  • North America
    • Segmentation by application
    • Segmentation by route of administration
  • Europe
    • Segmentation by application
    • Segmentation by route of administration
  • APAC
    • Segmentation by application
    • Segmentation by route of administration
  • South America
    • Segmentation by application
    • Segmentation by route of administration
  • The Middle East and Africa
    • Segmentation by application
    • Segmentation by route of administration

info_region

Competitive Landscape

This report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies in order to help clients improve their market positions. It also provides a detailed analysis of the upcoming pharmaceutical drug delivery market trends and challenges and how they will influence market growth, designed to help companies create effective strategies to make the most of the global market.

Companies leading the global pharmaceutical drug delivery market include:

  • Sanofi S.A.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Bayer AG
  • Novartis AG

info_keycomapnies

Market Dynamics

In order to make informed business decisions and strategies, it’s important to be informed of the many factors impacting the market. What is driving growth in the market and how does that influence new product releases? What challenges are increasing risk for a specific course of action or in a specific market? What will the key trends be over the next several years and what is the best way to take advantage of them? The answers to these questions help companies to evaluate business approaches and develop growth strategies.

There are many advancements being made in drug delivery methods and technologies. These advancements bring benefits such as greater drug efficacy and reduced side effects, resulting in more patient-friendly drug delivery systems. This can increase patient compliance and safety, and also help facilitate self-administrative medication. Examples of drug delivery systems include tablets and capsules, inhalation products, transdermal delivery systems, topical delivery systems, and injectable delivery systems.

FAQ

What are the different types of drug delivery systems used in pharmaceuticals?

Drug delivery systems include oral drug delivery (tablets, capsules), injectable drug delivery (injections, infusions), transdermal patches, inhalation systems, implantable devices, targeted drug delivery (nanoparticles, liposomes), and topical formulations (creams, ointments).

What are the key drivers of growth in the Pharmaceutical Drug Delivery Market?

Growth drivers include increasing prevalence of chronic diseases requiring long-term medication, advancements in biotechnology and nanotechnology for drug delivery, demand for patient-friendly drug administration methods, and the rise in biologics and personalized medicine.

How does regulatory oversight impact the Pharmaceutical Drug Delivery Market?

Regulatory bodies such as the FDA (Food and Drug Administration) in the United States and EMA (European Medicines Agency) in Europe set standards for drug delivery systems regarding safety, efficacy, quality control, and labeling requirements to ensure patient safety.

What are some recent advancements in the Pharmaceutical Drug Delivery Market?

Recent advancements include the use of nanotechnology for targeted drug delivery, development of biodegradable and bioresponsive materials, integration of digital health technologies for remote monitoring, and the emergence of personalized medicine approaches.

What challenges do companies face in the Pharmaceutical Drug Delivery Market?

Challenges include high development costs, stringent regulatory requirements, intellectual property protection, compatibility issues with different drug formulations, manufacturing scalability, and market competition from generic drugs and alternative therapies.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Exhibit 14: Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 15: Data Table on Regional - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 16: Chart on North America: Year-over-year growth 2023-2028 (%)
    • Exhibit 17: Data Table on Regional - Market size and forecast 2023-2028 ($ billion)

4 Historic Market Size

  • 4.1 Dietary supplements market in North America 2018 - 2022
    • Exhibit 18: Historic Market Size – Data Table on dietary supplements market in north America 2018 - 2022 ($ billion)
  • 4.2 Distribution Channel Segment Analysis 2018 - 2022
    • Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)
  • 4.3 Product Segment Analysis 2018 - 2022
    • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
  • 4.4 Geography Segment Analysis 2018 - 2022
    • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Exhibit 22: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Exhibit 23: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Exhibit 24: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Exhibit 25: Threat of new entrants – Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Exhibit 26: Threat of substitutes – Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Exhibit 27: Threat of rivalry – Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Exhibit 28: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
    • Exhibit 29: Chart on Distribution Channel - Market share 2023-2028 (%)
    • Exhibit 30: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 6.2 Comparison by Distribution Channel
    • Exhibit 31: Chart on Comparison by Distribution Channel
    • Exhibit 32: Data Table on Comparison by Distribution Channel
  • 6.3 Offline - Market size and forecast 2023-2028
    • Exhibit 33: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 34: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 35: Chart on Offline - Year-over-year growth 2023-2028 (%)
    • Exhibit 36: Data Table on Offline - Year-over-year growth 2023-2028 (%)
  • 6.4 Online - Market size and forecast 2023-2028
    • Exhibit 37: Chart on Online - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 38: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 39: Chart on Online - Year-over-year growth 2023-2028 (%)
    • Exhibit 40: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Distribution Channel
    • Exhibit 41: Market opportunity by Distribution Channel ($ billion)
    • Exhibit 42: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Product

  • 7.1 Market segments
    • Exhibit 43: Chart on Product - Market share 2023-2028 (%)
    • Exhibit 44: Data Table on Product - Market share 2023-2028 (%)
  • 7.2 Comparison by Product
    • Exhibit 45: Chart on Comparison by Product
    • Exhibit 46: Data Table on Comparison by Product
  • 7.7 Others - Market size and forecast 2023-2028
    • Exhibit 63: Chart on Others - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 64: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
    • Exhibit 65: Chart on Others - Year-over-year growth 2023-2028 (%)
    • Exhibit 66: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.8 Market opportunity by Product
    • Exhibit 67: Market opportunity by Product ($ billion)
    • Exhibit 68: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Exhibit 70: Chart on Market share by geography - 2023-2028 (%)
    • Exhibit 71: Data Table on Market share by geography - 2023-2028 (%)
  • 9.2 Geographic comparison
    • Exhibit 72: Chart on Geographic comparison
    • Exhibit 73: Data Table on Geographic comparison
  • 9.6 Market opportunity by geography
    • Exhibit 74: Market opportunity by geography ($ billion)
    • Exhibit 75: Data Table on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Exhibit 76: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
    • Exhibit 77: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
    • Exhibit 78: Overview on factors of disruption
  • 11.4 Industry risks
    • Exhibit 79: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
    • Exhibit 80: Vendors covered
  • 12.2 Market positioning of vendors
    • Exhibit 81: Matrix on vendor position and classification
  • 13 Appendix
  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Exhibit 82: Inclusions checklist
    • Exhibit 83: Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Exhibit 84: Currency conversion rates for US$
  • 13.4 Research methodology
    • Exhibit 85: Research methodology
    • Exhibit 86: Validation techniques employed for market sizing
    • Exhibit 87: Information sources
  • 13.5 List of abbreviations
    • Exhibit 88: List of abbreviations